Organigram (TSE:OGI) Trading Down 1.3% – Should You Sell?

Organigram Holdings Inc. (TSE:OGI)’s share price dropped 1.3% on Tuesday . The company traded as low as C$2.33 and last traded at C$2.34. Approximately 97,020 shares changed hands during trading, a decline of 58% from the average daily volume of 231,158 shares. The stock had previously closed at C$2.37.

Organigram Price Performance

The company has a market cap of C$314.64 million, a P/E ratio of -12.06, a P/E/G ratio of 0.42 and a beta of 2.11. The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. The firm has a 50 day moving average price of C$2.33 and a two-hundred day moving average price of C$2.28.

Insider Buying and Selling

In related news, insider Katrina May Mcfadden sold 11,655 shares of Organigram stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total value of C$29,020.95. Following the completion of the transaction, the insider directly owned 30,326 shares in the company, valued at approximately C$75,511.74. The trade was a 27.76% decrease in their position. Also, insider Paolo De Luca sold 12,007 shares of Organigram stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total value of C$29,897.43. Following the completion of the transaction, the insider owned 35,768 shares of the company’s stock, valued at approximately C$89,062.32. This trade represents a 25.13% decrease in their ownership of the stock. Insiders sold 161,555 shares of company stock worth $385,351 in the last 90 days. 31.32% of the stock is currently owned by company insiders.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.